8. Stock Compensation

The Company’s 2021 Long-Term Incentive Plan (the “2021 Plan”) was adopted by the Board of Directors on March 4, 2021, amended by the Board of Directors on April 20, 2021, and approved by shareholders in the annual shareholder meeting on April 29, 2021. The 2021 Plan authorizes the Compensation and Management Development Committee of the Board of Directors (“Compensation Committee”) to issue up to 2,000,000 additional various stock awards including stock options, performance stock units, restricted stock units and other forms of equity-based awards to key employees and directors. No new awards may be issued under the 2021 Plan after March 16, 2024.

The Company’s 2024 Long-Term Incentive Plan (the “2024 Plan”) was adopted by the Board of Directors on February 29, 2024, and approved by shareholders in the annual shareholder meeting on April 25, 2024. The 2024 Plan authorizes the Compensation Committee to issue up to 2,500,000 additional various stock awards including stock options, performance stock units, restricted stock units and other forms of equity-based awards to key employees and directors.

Stock compensation expense was approximately $3.5 million, $1.7 million and $6.7 million for the years ended December 31, 2025, 2024 and 2023, respectively, and is included in Selling, general and administrative expenses. Changes in expected performance under performance share award arrangements can cause volatility in stock compensation expense. Total unrecognized compensation cost related to non-vested share-based compensation arrangements at December 31, 2025 was approximately $5.3 million, which will be recognized over the next three years, as such compensation is earned. Outstanding options expire, if unexercised, ten years from the date of grant.

Options granted in 2025 are shown in the table below. There were no options granted in 2024 and 2023.

 

Year

 

Options

 

 

Exercise
Price

 

2025

 

 

125,000

 

 

$

10.75

 

Options exercised in 2024 and 2023 are shown in the table below. There were no options exercised in 2025.

 

Year

 

Options Exercised

 

 

Exercised
Price

2024

 

 

102,468

 

 

$18.58 to $21.30

2023

 

 

62,551

 

 

$11.62 to $18.69

 

In addition, options totaling 3,317, 20 and 43,729 expired or were forfeited during the years ended December 31, 2025, 2024 and 2023, respectively.

Options outstanding and exercisable at December 31, 2025, 2024 and 2023 were as follows:

 

Year

 

Outstanding

 

 

Range of Exercise
Prices

 

Exercisable

 

 

Weighted Average
Exercise Price

 

2025

 

 

137,797

 

 

$10.75 to $21.30

 

 

12,797

 

 

$

17.13

 

2024

 

 

16,114

 

 

$11.62 to $21.30

 

 

16,114

 

 

$

17.43

 

2023

 

 

118,602

 

 

$11.62 to $21.30

 

 

118,602

 

 

$

20.35

 

 

The fair value of options granted is estimated using an option pricing model based on the assumptions set forth in the following table. The Company uses historical data to estimate employee exercise and departure behavior. The risk free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant and through the expected term. The dividend yield rate is based on the Company’s historical dividend yield. The expected volatility is derived from historical volatility of the Company’s shares and those of similar companies measured against the market as a whole. The Company uses the binomial lattice option pricing model based on the assumptions set forth in the following table.

 

 

 

2025

Risk free interest rate

 

4.29%

Expected dividend yield

 

4.90%

Expected life of award (years)

 

6.13

Expected volatility

 

41.56%

Fair value per option

 

$3.22

 

The following table provides a summary of stock option activity for the period ended December 31, 2025:

 

 

 

Shares

 

 

Average
Exercise
Price

 

 

Weighted
Average
Life (in Years)

 

Outstanding at December 31, 2024

 

 

16,114

 

 

$

17.43

 

 

 

 

Options granted

 

 

125,000

 

 

 

10.75

 

 

 

 

Options exercised

 

 

 

 

 

 

 

 

 

Canceled or forfeited

 

 

(1,817

)

 

 

18.58

 

 

 

 

Expired

 

 

(1,500

)

 

 

18.69

 

 

 

 

Outstanding at December 31, 2025

 

 

137,797

 

 

 

11.34

 

 

 

8.33

 

Exercisable at December 31, 2025

 

 

12,797

 

 

$

17.13

 

 

 

1.70

 

 

The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option. There were no options exercised in 2025. The intrinsic value of stock options exercised in 2024 and 2023 was $0.1 million and $0.4 million, respectively. The intrinsic value of stock options outstanding at December 31, 2025 was $1.0 million.

The following table provides a summary of restricted stock units, including performance-based restricted stock units, and restricted stock activity for the year ended December 31, 2025:

 

 

 

Shares

 

 

Average
Grant-Date
Fair Value

 

Unvested shares at December 31, 2024

 

 

943,855

 

 

 

 

Granted

 

 

509,417

 

 

$

13.60

 

Vested

 

 

(261,228

)

 

$

19.65

 

Canceled or forfeited

 

 

(272,952

)

 

$

17.79

 

Unvested shares at December 31, 2025

 

 

919,092

 

 

 

 

 

Restricted stock units are rights to receive shares of common stock, subject to forfeiture and other restrictions, which vest over a one to three year period. Restricted stock units are considered to be non-vested shares under the accounting guidance for share-based payment and are not reflected as issued and outstanding shares until the restrictions lapse. At that time, the shares are released to the grantee and the Company records the issuance of the shares. At December 31, 2025, restricted stock awards had vesting periods through October 2028. Included in the December 31, 2025 unvested shares are 562,353 performance-based restricted stock units.

Free Sentinel

Want the next MYERS INDUSTRIES INC stock compensation disclosure the moment it drops?

Set a Sentinel and we'll alert you the moment MYERS INDUSTRIES INC's next filing hits EDGAR. No credit card, your email never gets sold.

Track for free

Historical Timeline

Fiscal YearFiled
2025Mar 5, 2026Showing above
2024Mar 6, 2025
2023Mar 5, 2024
2022Mar 3, 2023
2021Mar 10, 2022
2020Mar 11, 2021
2019Mar 6, 2020
2018Mar 8, 2019
2017Mar 9, 2018
2016Mar 9, 2017
2015Mar 14, 2016

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.